About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Neurovascular Devices Market Size, Top Share, Forecast to 2031
Neurovascular Devices Market

Neurovascular Devices Market Size, Share & Trends Analysis Report By Product (Embolization Devices, Revascularization Devices Inactivated Vaccines, Thrombectomy Devices, Embolic Protection Devices, Accessory Devices), By Disease Pathology (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54276DR
Last Updated : November 14, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Neurovascular Devices Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Neurovascular Devices Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. B. Braun Melsungen AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Integer Holdings Corporation
    3. Johnson & Johnson
    4. Microport Scientific Corporation
    5. Penumbra, INC.
    6. Phenox GmbH
    7. Stryker Corporation
    8. Terumo Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Neuroendoscopy Devices Market Size The global neuroendoscopy devices market size was valued at USD 442.86 million in 2024 and is projected to grow from USD 489.98 million in 2025 to USD 867.00 million by 2033, exhibiting a&n
Buy Now
Global Report
The global neurostimulation devices market size was valued at USD 6 billion in 2021 and is valued at USD 14 billion by 2030. The market is expected to grow at a CAGR of 13% during the forecast period (2022–2030). Factors such as increasing geri
Buy Now
Global Report
The neurosurgery device market was valued at USD 7,280 million in 2019 and is expected to grow with a CAGR of 13.2% during the forecast period. Neurosurgical instruments are used in surgical treatments of a variety of neurological conditions and dis
Buy Now
Global Report
The global neurovascular catheters market was valued at USD 3.12 billion in 2021. It is projected to reach USD 5.54 billion by 2030, growing at a CAGR of 6.6% during the forecast period (2022–2030). Factors such as Rising Prevalence of Hemorrha
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.